🌐EnglishEnglishBahasa IndonesiaDeutschFrançaisItalianoNederlandsPolskiTiếng ViệtTürkçeРусскийالعربيةفارسی中文日本語EntityQ412909· pop 19· linked from 285 articlescertolizumab pegolpharmaceutical drugResearch1,417 papersCertolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2020Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.Annals of the rheumatic diseases · 2025Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy.Skin therapy letter · 2021Certolizumab pegol.mAbs · 2010Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.Annals of the rheumatic diseases · 2023via PubMedConnectionsUnited States Food and Drug AdministrationEntitymonoclonal antibodyEntityCategoriesBelgian inventionsBiotechnologyChemicals that do not have a ChemSpider ID assignedDisease-modifying antirheumatic drugsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs that are a monoclonal antibodyDrugs with non-standard legal statusImmunosuppressantsMonoclonal antibodiesTNF inhibitors